[1] Carter CL, Resnick EM, Mallampalli M, et al.Sex and gender differences in Alzheimer’s disease: Recommendations for future research[J].J Womens Health,2012,21(10):1018-1023.
[2] Prince M, Wimo A, Guerchet M, et al.World Alzheimer Report 2015 the global impact of dementia: An analysis of prevalence, incidence, cost, and trends[M].London: King’s College,2015:1-57.
[3] Jia J, Wei C, Chen S, et al.The cost of Alzheimer's disease in China and re-estimation of costs worldwide[J].Alzheimers Dement,2018,14(4):483-491.
[4] 葛珊珊,张志将.1990—2017年中国阿尔茨海默病疾病负担趋势分析[J].中国慢性病预防与控制,2021,29(9):718-722.
[5] 丁贤彬,焦艳,毛德强,等.2012—2018年重庆市阿尔茨海默病死亡率及疾病负担变化趋势[J].中国慢性病预防与控制,2020,28(9):665-668.
[6] 中国疾病预防控制中心慢性非传染性疾病预防控制中心.人口死因监测工作指导手册[M].北京:中国人口出版社,2017:289-299.
[7] 侯焱堃. 基于Leslie模型的人口增长预测与研究[J].科技创新与应用,2014(27):35-36.
[8] GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017BD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2018,392(10159): 1859-1922.
[9] GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE),1990-2015: A systematic analysis for the global burden of disease study 2015BD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE),1990-2015: A systematic analysis for the global burden of disease study 2015[J].Lancet,2016,388(10053):1603-1658.
[10] Zheng XY, Xu XJ, Liu YY, et al.Age-standardized mortality, disability-adjusted life-years and healthy life expectancy in different cultural regions of Guangdong, China: A population-based study of 2005-2015[J].BMC Public Health,2020,20(1):858.
[11] 孟军,毛玮,黄金梅.广西2013—2017年死因监测点主要慢性病早死概率及变化趋势[J].中国热带医学,2019,19(3):220-224.
[12] 曾新颖,齐金蕾,殷鹏,等.1990—2016年中国及省级行政区疾病负担报告[J].中国循环杂志,2018,33(12):1147-1158.
[13] Bo Z, Wan Y, Meng SS, et al.The temporal trend and distribution characteristics in mortality of Alzheimer’s disease and other forms of dementia in China:Based on the National Mortality Surveillance System (NMS) from 2009 to 2015[J].PLoS One,2019,14(1):e0210621.
[14] Feigin V, Murray CJ, Brayne C, et al.Global, regional, and national burden of Alzheimer's disease and other dementias,1990-2016[J].Lancet Neurol,2018, 18:88-106.
[15] Xu Y, Wang L, He J, et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-958.
[16] 安娜,卓思思,张海燕.张家口市老年人轻度认知功能障碍患病现状及影响因素分析[J].华南预防医学,2020,46(4):401-404.
[17] 孙环,乔永涛,夏昱,等.社区老年居民认知功能现状调查及其影响因素[J].华南预防医学,2021,47(2):166-169. |
